URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) of thromboelastography (TEG) as a screening method for
products that affect the hemostatic system, the safety assessment
Lu, Enzhou,
Gareev, Ilgiz,
Yuan, Chao,
Liang, Yanchao,
Sun, Jingxian,
Chen, Xin,
Beylerli, Ozal,
Sufianov, Albert,
Zhao, Shiguang,
Yang, Guang (2022) to platinum drugs is the result of a combination of influencing
factors. Decreased intracellular drug
, mutations at the 5’-end of the gene, causing a shortening of the protein
product, are associated with optic
, without
harming the fetus, especially in the third trimester, the method of gradual compression
, without
harming the fetus, especially in the third trimester, the method of gradual compression
Masalimova, D.I.,
Pogosov, G.R.,
Abdullaev, O.A.,
Vasnetsov, B.N.,
Dolgopolova, I.V.,
Osmanov, G.G. (2022) on the child. Conversely, the patient’s refusal of the necessary treatment due to potential
harm to the fetus